018221793

SUPLEXACELLS

---

April 2, 2020

Trademark Summary

The trademark application SUPLEXACELLS was filed by Alloplex Biotherapeutics, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on July 9, 2020, and it was registered by office on October 19, 2020 without any oppositions.

The application was filed in English (German was selected as the second language).

---

Goods And Services

• The mark was filed in class 5 with Stimulated autologous blood cells for the treatment of cancer.
• The mark was filed in class 44 with Cell therapy services involving use of stimulated autologous blood cells for the treatment of cancer.